|
1
|
Ruiz-Bailén M, Aguayo de Hoyos E,
Ramos-Cuadra JA, et al: Influence of age on clinical course,
management and mortality of acute myocardial infarction in the
Spanish population. Int J Cardiol. 85:285–296. 2002.PubMed/NCBI
|
|
2
|
Polewczyk A, Janion M, Gasior M, et al:
Benefits from revascularisation therapy in the elderly with acute
myocardial infarction. Comparative analysis of patients
hospitalised in 1992–1996 and in 2005–2006. Kardiol Pol.
68:873–881. 2010.PubMed/NCBI
|
|
3
|
De Luca G, Suryapranata H, Dambrink JH, et
al: Sex-related differences in outcome after ST-segment elevation
myocardial infarction treated by primary angioplasty: data from the
Zwolle Myocardial Infarction study. Am Heart J. 148:852–856.
2004.
|
|
4
|
Griffith D, Hamilton K, Norrie J and Isles
C: Early and late mortality after myocardial infarction in men and
women: prospective observational study. Heart. 91:305–307. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bickel C, Rupprecht HJ, Blankenberg S, et
al: Serum uric acid as an independent predictor of mortality in
patients with angiographically proven coronary artery disease. Am J
Cardiol. 89:12–17. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Short RA, Johnson RT and Tuttle KR: Uric
acid, microalbuminuria and cardiovasular events in high-risk
patients. Am J Nephrol. 25:36–64. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Car S and Trkulja V: Higher serum uric
acid on admission is associated with higher short-term mortality
and poorer long-term survival after myocardial infarction:
retrospective prognostic study. Croat Med J. 50:559–566. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Washio T, Nomoto K, Watanabe I, et al:
Relationship between plasma homocysteine levels and congestive
heart failure in patients with acute myocardial infarction.
Homocysteine and congestive heart failure. Int Heart J. 52:224–228.
2011. View Article : Google Scholar
|
|
9
|
Kadri Z, Danchin N, Vaur L, et al: Major
impact of admission glycaemia on 30 day and one year mortality in
non-diabetic patients admitted for myocardial infarction: results
from the nationwide French USIC 2000 study. Heart. 92:910–915.
2006.PubMed/NCBI
|
|
10
|
Coyal A, Mehta SR, Gerstein HC, et al:
Glucose levels compared with diabetes history in the risk
assessment of patients with acute myocardial infarction. Am Heart
J. 157:763–770. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ishihara M, Kojima S, Sakomoto T, et al:
Comparison of blood glucose value on admission for acute myocardial
infarction in patients with versus without diabetes mellitus. Am J
Cardiol. 104:769–774. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wahab NN, Cowden EA, Pearce NJ, et al: Is
blood glucose an independent predictor of mortality in acute
myocardial infarction in the thrombolytic era? J Am Coll Cardiol.
40:1748–1754. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ceriello A: Acute hyperglycaemia: a ‘new’
risk factor during myocardial infarction. Eur Heart J. 26:328–331.
2005.
|
|
14
|
Norhamraar A, Tenerz A, Nilsson G, et al:
Glucose metabolism in patients with acute myocardial infarction and
no previous diagnosis of diabetes meullitus: a prospective study.
Lancet. 359:2140–2l. 44:2002.PubMed/NCBI
|
|
15
|
Yan MZ, Hu Dy, Yu JM, et al: Newly
diagnosed abnormal glucose tolerance in patients with acute
coronary syndrome and without known diabetes mellitus. Zhonghua Yi
Xue Za Zhi. 86:1256–1259. 2006.(In Chinese).
|
|
16
|
Gore JM, Goldberg RJ, Matsumoto AS, et al:
Validity of serum total cholesterol level obtained within 24 hours
of acute myocardial infarction. Am J Cardiol. 54:722–725. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fyfe T, Baxter RH, Cochran KM, et al:
Plasma-lipid changes after myocardial infarction. Lancet.
2:997–1001. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kitsis RN and Jialal I: Limiting
myocardial damage during acute myocardial infarction by inhibiting
C-reactive protein. N Engl J Med. 355:513–515. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gharacholou SM, Lopes RD, Alexander KP, et
al: Age and outcomes in ST-segment elevation myocardial infarction
treated with primary percutaneous coronary intervention: findings
from the APEX-AMI trial. Arch Intern Med. 171:559–567. 2011.
View Article : Google Scholar
|
|
20
|
Kala P, Kanovsky J, Rokyta R, et al:
Age-related treatment strategy and long-term outcome in acute
myocardial infarction patients in the PCI era. BMC Cardiovasc
Disord. 12:312012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tuomainen PO, Ylitalo A, Niemelä M, et al:
Gender-based analysis of the 3-year outcome of bioactive stents
versus paclitaxel-eluting stents in patients with acute myocardial
infarction: an insight from the TITAX-AMI trial. J Invasive
Cardiol. 24:104–108. 2012.PubMed/NCBI
|
|
22
|
Li Z, Li ZZ, Gao YL, et al: On-admission
serum uric acid predicts outcomes after acute myocardial
infarction: systematic review and meta-analysis of prognostic
studies. Zhonghua Xin Xue Guan Bing Za Zhi. 40:225–230. 2012.(In
Chinese).
|
|
23
|
Bae MH, Lee JH, Lee SH, et al: Serum uric
acid as an independent and incremental prognostic marker in
addition to N-terminal pro-B-type natriuretic peptide in patients
with acute myocardial infarction. Circ J. 75:1440–1447. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim SY, Guevara JP, Kim KM, et al:
Hyperuricemia and coronary heart disease: a systematic review and
meta-analysis. Arthritis Care Res (Hoboken). 62:170–180.
2010.PubMed/NCBI
|
